Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria

Hdl Handle:
http://hdl.handle.net/10144/347156
Title:
Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria
Authors:
Avong, Yohanna Kamabi; Isaakidis, Petros; Hinderaker, Sven Gudmund; Van den Bergh, Rafael; Ali, Engy; Obembe, Bolajoko Oladunni; Ekong, Ernest; Adebamowo, Clement; Ndembi, Nicaise; Okuma, James; Osakwe, Adeline; Oladimeji, Olanrewaju; Akang, Gabriel; Obasanya, Joshua Olusegun; Eltayeb, Osman; Agbaje, Aderonke Vivian; Abimiku, Alash'le; Mensah, Charles Olalekan; Dakum, Patrick Sunday
Journal:
PLoS One
Abstract:
Adverse events (AEs) of second line anti-tuberculosis drugs (SLDs) are relatively well documented. However, the actual burden has rarely been described in detail in programmatic settings. We investigated the occurrence of these events in the national cohort of multidrug-resistant tuberculosis (MDR-TB) patients in Nigeria.
Publisher:
Public Library of Science
Issue Date:
17-Mar-2015
URI:
http://hdl.handle.net/10144/347156
DOI:
10.1371/journal.pone.0120161
PubMed ID:
25781958
Language:
en
ISSN:
1932-6203
Appears in Collections:
TB

Full metadata record

DC FieldValue Language
dc.contributor.authorAvong, Yohanna Kamabien_GB
dc.contributor.authorIsaakidis, Petrosen_GB
dc.contributor.authorHinderaker, Sven Gudmunden_GB
dc.contributor.authorVan den Bergh, Rafaelen_GB
dc.contributor.authorAli, Engyen_GB
dc.contributor.authorObembe, Bolajoko Oladunnien_GB
dc.contributor.authorEkong, Ernesten_GB
dc.contributor.authorAdebamowo, Clementen_GB
dc.contributor.authorNdembi, Nicaiseen_GB
dc.contributor.authorOkuma, Jamesen_GB
dc.contributor.authorOsakwe, Adelineen_GB
dc.contributor.authorOladimeji, Olanrewajuen_GB
dc.contributor.authorAkang, Gabrielen_GB
dc.contributor.authorObasanya, Joshua Olusegunen_GB
dc.contributor.authorEltayeb, Osmanen_GB
dc.contributor.authorAgbaje, Aderonke Vivianen_GB
dc.contributor.authorAbimiku, Alash'leen_GB
dc.contributor.authorMensah, Charles Olalekanen_GB
dc.contributor.authorDakum, Patrick Sundayen_GB
dc.date.accessioned2015-03-26T14:28:57Z-
dc.date.available2015-03-26T14:28:57Z-
dc.date.issued2015-03-17-
dc.identifier.citationDoing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria. 2015, 10 (3):e0120161 PLoS ONEen_GB
dc.identifier.issn1932-6203-
dc.identifier.pmid25781958-
dc.identifier.doi10.1371/journal.pone.0120161-
dc.identifier.urihttp://hdl.handle.net/10144/347156-
dc.description.abstractAdverse events (AEs) of second line anti-tuberculosis drugs (SLDs) are relatively well documented. However, the actual burden has rarely been described in detail in programmatic settings. We investigated the occurrence of these events in the national cohort of multidrug-resistant tuberculosis (MDR-TB) patients in Nigeria.en_GB
dc.language.isoenen
dc.publisherPublic Library of Scienceen_GB
dc.rightsPublished by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permissionen_GB
dc.titleDoing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeriaen
dc.identifier.journalPLoS Oneen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.